Menu
0
    0

    Your Cart is Empty

    MAAC10 Nicotinamide Riboside 1000mg NR NAD+ Supplement.
    MAAC10 Nicotinamide Riboside 1000mg NR NAD+ Supplement.
    MAAC10 Nicotinamide Riboside 1000mg NR NAD+ Supplement.
    MAAC10 Nicotinamide Riboside 1000mg NR NAD+ Supplement.
    MAAC10 Nicotinamide Riboside 1000mg NR NAD+ Supplement.
    MAAC10 Nicotinamide Riboside 1000mg NR NAD+ Supplement.
    MAAC10 Nicotinamide Riboside 1000mg NR NAD+ Supplement.
    MAAC10 Nicotinamide Riboside 1000mg NR NAD+ Supplement.
    MAAC10 Nicotinamide Riboside 1000mg NR NAD+ Supplement.
    MAAC10 Nicotinamide Riboside 1000mg NR NAD+ Supplement.
    MAAC10 Nicotinamide Riboside 1000mg NR NAD+ Supplement.
    MAAC10 Nicotinamide Riboside 1000mg NR NAD+ Supplement.
    Sale

    MAAC10 Formulas

    MAAC10 Nicotinamide Riboside 1000mg NR NAD+ Supplement.

    $ 49.99 $ 89.99 You Save 44% ($ 40.00)

    MAAC10 Nicotinamide Riboside 1000mg Serving Size (4x250mg capsules) or choose your own dose 1x cap 250mg, 2x caps 500mg, 3x caps 750mg or 4x caps 1000mg.

    NAD+ Precursor Supplement.

    About this item

    • Nicotinamide Riboside works to increase low NAD levels. Our NR capsules work to support your longevity genes and encourage healthy aging. 
    • 1000MG PER SERVING - Maac10 NR capsules support health aging while also working to support healthy brain and metabolic function. 
    • 120 CAPSULES - Each bottle of Maac10 Nicotinamide Riboside comes with 120 easy-to-swallow capsules. Each serving is 4 x 250mg capsules or you can customize your dose. 
    • DISCOVER MAAC10 - At Maac10, we believe in proven scientific research to support your health and wellness. Our products are manufactured in a GMP and NSF Certified facility in Miami, Florida, USA. Support your longevity genes with supplements that support cellular respiration and mitochondrial health!
    • THIRD PARTY LAB TESTED - Results show 256.3 mg per capsule at 4 capsules per serving exceeding the label claim. MAAC10's focus has always been NAD support supplements since launch in 2015. 

    Subscribe